Josep Dalmau

The Guest Editor of this issue of Seminars in Neurology on the Neurologic Complications of Cancer is Josep Dalmau, M.D., Ph.D. Dr. Dalmau is returning as Guest Editor having previously edited the December 2004 issue of Seminars in Neurology. Dr. Dalmau is Professor of Neurology at the University of Pennsylvania, and Associate Investigator, Abramson Comprehensive Cancer Research Institute.

Dr. Dalmau received his Bachelor of Science degree from Instituto Nacional de Ensenanza Media, Ausias March, Barcelona, Spain. He received his M.D. from Autonoma University of Barcelona, Spain, and then did an Internship in Internal Medicine at University Hospital de la Sta. Cruz y San Pablo, Barcelona, Spain. He served as a physician in the Spanish Army Service followed by a Residency in Neurology at the University Hospital de la Sta. Cruz y San Pablo. He served on the Faculty of the University Hospital of Sabadell, Barcelona, and then became a Research Fellow in the Cortzias Laboratory of Neuro-Oncology at the Sloan-Kettering Institute in New York. This was followed by a Fellowship in Neuro-Oncology at Memorial Hospital for Cancer and Allied Disease in New York. He has been at the University of Pennsylvania since 2002.

Dr. Dalmau is a giant in the fields of neuro-oncology and neuroimmunology for his research in paraneoplastic disorders of the central nervous system and for his identification of novel antibodies and autoantigens in CNS autoimmune disorders. He has lectured throughout the world on immune-mediated encephalitis and autoimmunity to NMDA and other synaptic receptors. He has been invited to present his work at the World Congress of Neurology, the International Congress of Immunology, the Presidential Symposium of the American Neurological Association, the Pan-American Congress of Neurology, and at meetings sponsored by the American Academy of Neurology, the Spanish Academy of Neurology, the European Neurological Society, and many other national and international organizations. He has won several teaching awards and is a prolific author. He has written many definitive works; several of his articles have been highlighted and published with accompanying editorials. He is a tremendous leader and scholar in this critical area of neurology.

Dr. Dalmau credits his wife, Myrna Rosenfeld, M.D., Ph.D., a world-renowned neuro-oncologist, for much of the editing of this issue of Seminars in Neurology. We are grateful to both of them and to all of the authors for giving their time and expertise to this outstanding issue, and the contributions they make every day to the care of patients with cancer.